Zhang Z, Mascheri N, Dharmakumar R, Li D
Department of Radiology, Northwestern University, Chicago, Illinois 60611, USA.
Cytotherapy. 2008;10(6):575-86. doi: 10.1080/14653240802165699.
There is rapidly increasing interest in the use of magnetic resonance imaging (MRI) to track cell migration in vivo. Iron oxide MR contrast agents can be detected at micromolar concentrations of iron, and offer sufficient sensitivity for T2*-weighted imaging. Cellular MRI shows potential for assessing aspects of cardiovascular disease. Labeling in vivo and tracking macrophages using iron oxide nanoparticles has been a goal for cellular MRI because macrophages play a pivotal role in the pathophysiology of many human diseases, including atherosclerosis. Cellular MRI has also been using to track transplanted therapeutic cells in myocardial regeneration. This review looked at iron oxide nanoparticles, methods of cell labeling, image acquisition techniques and limitations encountered for visualization. Particular attention was paid to stem cells and macrophages for the cardiovascular system.
使用磁共振成像(MRI)在体内追踪细胞迁移的兴趣正在迅速增加。氧化铁磁共振造影剂在微摩尔浓度的铁时即可被检测到,并且对T2*加权成像具有足够的灵敏度。细胞MRI在评估心血管疾病方面显示出潜力。使用氧化铁纳米颗粒在体内标记并追踪巨噬细胞一直是细胞MRI的目标,因为巨噬细胞在包括动脉粥样硬化在内的许多人类疾病的病理生理学中起着关键作用。细胞MRI也已用于追踪心肌再生中移植的治疗性细胞。本综述探讨了氧化铁纳米颗粒、细胞标记方法、图像采集技术以及可视化过程中遇到的局限性。特别关注了心血管系统中的干细胞和巨噬细胞。